Market Insights:
The ELISpot and FluoroSpot Assay are using to detect various antibodies, cytokines, and granzymes. ELISpot and FluoroSpot Assay are a sensitive technique used for the recognition of immune cells which specific proteins such as cytokines or antibodies. These kits are applicable for early diagnose diseases such as TB and tick-borne diseases. In these techniques’ cells are cultured on plates that are coated with antibodies which capture specific target molecules. The distribution of these analytes is then spotted through a sandwich ELISA where the analyte is capture.
The Global ELISpot and FluoroSpot assay market were estimated USD 135 million in 2017 and expected to reach USD 287 million by 2023 at a CAGR of 16.2% during the forecast period.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6948
The factor contributing for the market growth of ELISpot and FluoroSpot assay kits are increasing development for new vaccines for various treatments and innovation in pharma & biotech industry for the development of vaccines, rising clinical trials and growing healthcare expenditure by the population. However, factors such as high cost of ELISpot and FluoroSpot assay, lack of skilled technicians and alternative techniques are expected to hinder the growth of ELISpot and FluoroSpot assay market during the forecast period.
Key players:
- Oxford Immunotec
- Cellular Technologies
- Mabtech
- Becton, Dickinson and Company
- Abcam
- Bio-Techne
- Autoimmun Diagnostika
- Biotech Investissement
- Lophius Biosciences
- U-CyTech
Segmentation:
The Global ELISpot and FluoroSpot Assay Market is segmented on the basis of product, application, and end-user. The ELISpot and FluoroSpot Assay market, by product is categorised into various assay kit, analyzer, ancillary products. The assay kit is sub-segmented into T Cell assay and B Cell assay. On the basis of application, the market is segmented into transplant, vaccines development, clinical trials, cancer treatment. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centres, diagnostic centres, research centers, and others.
Regional Analysis:
Europe stood second largest in the ELISpot and FluoroSpot Assay market owing to the increasing number of pharmaceutical companies, rising in the development of innovative vaccines for the treatment of various viral diseases. The growing funding from government and private agencies for drug development also support the ELISpot and FluoroSpot Assay market in this region. Asia-Pacific was estimated to be the fastest growing region for the global ELISpot and FluoroSpot Assay market in 2017. The market is expected to witness growth owing to the rising prevalence of viral infection, increasing geriatric population in this region and growing demand for ELISpot and FluoroSpot Assay in research field.
The Middle East and Africa holds the least share in the global ELISpot and FluoroSpot Assay market due to the presence of low health expenditure, lack of skilled technicians and less pharmaceutical company in this region. However, the market is expected to witness growth due to increasing research & development in the Middle East.
Browse Premium Research Report @https://www.marketresearchfuture.com/reports/elispot-and-fluorospot-assay-market-6948
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/elispot-and-fluorospot-assay-market-6948